Skip to main content

and
  1. Article

    Open Access

    CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma

    Comparative genetic and biological studies on malignant tumor counterparts in human beings and laboratory mice may be powerful gene discovery tools for blood cancers, including neoplasms of mature B-lymphocyte...

    Seong-Su Han, Van S Tompkins, Dong-Ju Son in Experimental Hematology & Oncology (2015)

  2. No Access

    Article

    Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma

    Studies on the biologic and molecular genetic underpinnings of multiple myeloma (MM) have identified the pleiotropic, pro-inflammatory cytokine, interleukin-6 (IL-6), as a factor crucial to the growth, prolife...

    Timothy R. Rosean, Van S. Tompkins, Guido Tricot, Carol J. Holman in Immunologic Research (2014)

  3. Article

    Open Access

    NF-κB/STAT3/PI3K signaling crosstalk in iMyc B lymphoma

    Myc is a well known driver of lymphomagenesis, and Myc-activating chromosomal translocation is the recognized hallmark of Burkitt lymphoma, an aggressive form of non-Hodgkin's lymphoma. We developed a model th...

    Seong-Su Han, Hwakyung Yun, Dong-Ju Son, Van S. Tompkins in Molecular Cancer (2010)